Avoid common mistakes on your manuscript.
Retraction Note: BMC Cancer 19, 1160 (2019)
The Editors have retracted this article following an investigation by the Chinese Ministry of Science and Technology. The investigation found the data presented here is unreliable and that the corresponding author Yongjun Mao was not aware of the publication. The Editors therefore no longer have confidence in the integrity of the data in this article.
None of the authors have responded to any correspondence from the editor/publisher about this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12885-019-6381-y.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Wang, S., Zhang, X., Wang, G. et al. Retraction Note: Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells. BMC Cancer 24, 277 (2024). https://doi.org/10.1186/s12885-024-12036-9
Published:
DOI: https://doi.org/10.1186/s12885-024-12036-9